Correction: BMC Cancer 24, 830 (2024)
https://doi.org/10.1186/s12885-024-12579-x
Following publication of the original article [1], a typesetting error was reported. The initials of author Kailiang Zhao (ZK) were erroneously added to the author group. This has been removed in this correction article.
Further to this, the authors reported an error in Table 1, whereby the last row in the table was omitted.
The incorrect Table 1:
The corrected Table 1:
The original article [1] has been corrected.
Reference
Ma W, Shi Q, Zhang L, et al. Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies. BMC Cancer. 2024;24:830. https://doi.org/10.1186/s12885-024-12579-x.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Ma, W., Shi, Q., Zhang, L. et al. Correction: Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies. BMC Cancer 24, 844 (2024). https://doi.org/10.1186/s12885-024-12638-3
Published:
DOI: https://doi.org/10.1186/s12885-024-12638-3